EPN Shares Epsilon Healthcare Limited
ASX · ASXLast in our picks 2026-09-22 — not in the current list; analysis below is from that screen
Not a consumer staples name; included only if sector screen is broad and investable.
Signal breakdown
- ▸Weak sector fit and limited staples relevance.
- ▸Above 50-day MA (+20.53%)
- ▸Above 200-day MA — long-term uptrend
Is EPN a buy right now?
Trend: EPN is trading below the 50-day average (-30.00%), RSI 32 — neutral momentum, with a 3-month return of -8.70%.
Valuation & quality: Epsilon Healthcare Limited trades on price-to-book 2.10; fundamentals show net margin 0.5%, return on equity 50.3%, revenue growth 123.0% year on year.
Our screen: BUY (score 2) — Not a consumer staples name; included only if sector screen is broad and investable.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -33.30% | +0.00% | +0.00% | +0.00% | +50.00% | -33.30% | +50.00% | -33.30% |
Fundamentals
Technical signals
About Epsilon Healthcare Limited
Epsilon Healthcare Limited, together with its subsidiaries, engages in the healthcare business in Australia. The company operates in three segments, Contract Development and Manufacturing Activities, Telehealth Medical Practice Services, and Pharmacy Services.
Sector: Healthcare · Industry: Drug Manufacturers - Specialty & Generic · Australia · Website
Related Consumer Staples picks
Browse: all ASX stocks · Consumer Staples picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.